Operating Lease, Payments in USD of Ambrx Biopharma Cayman, Inc. from 2019 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Ambrx Biopharma Cayman, Inc. quarterly/annual Operating Lease, Payments history and change rate from 2019 to Q2 2023.
  • Ambrx Biopharma Cayman, Inc. Operating Lease, Payments for the quarter ending 30 Jun 2023 was $673,000.000, a 227% increase year-over-year.
  • Ambrx Biopharma Cayman, Inc. annual Operating Lease, Payments for 2022 was $1,874,000.000, a 7.58% increase from 2021.
  • Ambrx Biopharma Cayman, Inc. annual Operating Lease, Payments for 2021 was $1,742,000.000, a 2.96% increase from 2020.
  • Ambrx Biopharma Cayman, Inc. annual Operating Lease, Payments for 2020 was $1,692,000.000, a 3.05% increase from 2019.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Change (%)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Change (%)

Ambrx Biopharma Cayman, Inc. Quarterly Operating Lease, Payments (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $673,000 +$467,000 +2.3% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2023
Q1 2023 $731,000 +$134,000 +22.4% 01 Jan 2023 31 Mar 2023 10-Q 11 May 2023
Q2 2022 $206,000 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023
Q1 2022 $597,000 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023

Ambrx Biopharma Cayman, Inc. Annual Operating Lease, Payments (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $1,874,000 +$132,000 +7.6% 01 Jan 2022 31 Dec 2022 10-K 30 Mar 2023
2021 $1,742,000 +$50,000 +3% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023
2020 $1,692,000 +$50,000 +3% 01 Jan 2020 31 Dec 2020 20-F 26 Apr 2022
2019 $1,642,000 01 Jan 2019 31 Dec 2019 20-F 26 Apr 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.